Arkady Broder, MD
Gastroenterology · Brick, NJNPI 1336307529
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $13,115 of the $21,199 with a category attached, or 61.9%. 17 manufacturers reported payments, led by Johnson & Johnson at 53.2% of the total. 2025 is the largest year on record at $8,877, 2.2 times the $4,090 reported in 2019. Among gastroenterology clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 172 payments — averaging $123.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$11K
- Olympus America Inc.$7K
- AbbVie$1K
- Boston Scientific$525
- Takeda Pharmaceuticals U.S.A., Inc.$447
- Integra Lifesciences Corporation$174
- plus $325 from 11 others
What the payments were for
- Consulting fees$13,11562%
- Speaking & faculty fees$4,95023%
- Food & beverage$3,03914%
- Education$940%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 33 | $11,288 |
| Olympus America Inc. | 17 | $6,994 |
| AbbVie | 58 | $1,445 |
| Boston Scientific | 13 | $525 |
| Takeda Pharmaceuticals U.S.A., Inc. | 32 | $447 |
| Integra Lifesciences Corporation | 1 | $174 |
| Lilly USA, LLC | 4 | $71 |
| Bristol Myers Squibb | 4 | $59 |
| Fujifilm Healthcare Americas Corporation | 1 | $48 |
| Ferring Pharmaceuticals Inc. | 2 | $32 |
| Medtronic | 1 | $23 |
| Merck | 1 | $18 |
| Capsovision, Inc. | 1 | $17 |
| Pfizer | 1 | $16 |
| Amgen | 1 | $14 |
| Sandoz | 1 | $14 |
| Nestle Healthcare Nutrition Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tremfya$8,845
- Olympus Biliary Devices$3,780
- STELARA$3,485
- VISIGLIDE$3,080
- Skyrizi$618
- INTEGRA$523
- INTEGRA DERMAL REGENERATION TEMPLATE$174
- PRIMATRIX$174
- Rinvoq$130
- EXALT Model D$116
How this compares
$21,199 in reported general payments places this provider in the 90th percentile of 701 gastroenterology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 15 | $241,738 |
| RinvoqUpadacitinib | 11 | $104,265 |
| InflectraInfliximab-Dyyb | 12 | $85,868 |
| CreonLipase/Protease/Amylase | 22 | $51,480 |
| LinzessLinaclotide | 28 | $30,601 |
| Dexlansoprazole DrDexlansoprazole | 29 | $9,027 |
| Mesalamine | 20 | $7,456 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 26 | $4,179 |
| Omeprazole | 277 | $3,343 |
| Ursodiol | 14 | $2,414 |
| Sucralfate | 14 | $2,226 |
| Pantoprazole Sodium | 128 | $1,925 |
| Esomeprazole Magnesium | 27 | $947 |
| Dicyclomine Hcl | 25 | $606 |
| Famotidine | 53 | $574 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq, Creon, Linzess | $1,445 | $186,34761 claims |
| PfizerInflectra | $16 | $85,86812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 701 gastroenterology providers in New Jersey.
Other gastroenterology in Brick
- Mark CereficeBrick$25K
- Kenny ChiuBrick$15K
- Kenny HuiBrick$15K
- Vinod RustgiNew Brunswick$431K
- Zamir BrelviNewark$391K
- Adam ElfantMount Laurel$385K
- Devjit NayarHoboken$258K
- Lea ChenNew Brunswick$185K
- Alexander PerelmanWest Orange$160K
- Barry KaufmanEgg Harbor Township$157K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.